Validation Accelerated
Source: Asymchem

There’s always a need for speed with drug development. But Asymchem redefined expectations: moving from zero to validation in 14 months.
Challenge
A major pharma company’s need for scale-up and validation of a cGMP intermediate had been delayed for a while when the US FDA suddenly granted it priority status. Almost overnight, validation and supply were required.
VIEW THE CASE STUDY!
Log In
Signing up provides unlimited access to:
Free Sign Up

Signing up provides unlimited access to:
- Trend and Leadership Articles
- Case Studies
- Extensive Product Database
- Premium Content
HELLO. PLEASE LOG IN.
X
Not yet a member of Pharmaceutical Online? Register today.
ACCOUNT SIGN UP
X
Please fill in your account details
ACCOUNT SIGN UP
Asymchem
This website uses cookies to ensure you get the best experience on our website. Learn more